Spectral Medical Inc
TSX:EDT

Watchlist Manager
Spectral Medical Inc Logo
Spectral Medical Inc
TSX:EDT
Watchlist
Price: 1.28 CAD -2.29% Market Closed
Market Cap: 370.1m CAD

Relative Value

The Relative Value of one EDT stock under the Base Case scenario is 0.22 CAD. Compared to the current market price of 1.28 CAD, Spectral Medical Inc is Overvalued by 83%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

EDT Relative Value
Base Case
0.22 CAD
Overvaluation 83%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
4
vs Industry
14
Median 3Y
74.1
Median 5Y
61.7
Industry
7.9
Forward
205.3
vs History
vs Industry
Median 3Y
-8.8
Median 5Y
-9.2
Industry
24
Forward
-21.1
vs History
vs Industry
Median 3Y
-15.5
Median 5Y
-14.6
Industry
21.6
vs History
vs Industry
3
Median 3Y
-26.6
Median 5Y
-17.1
Industry
23.7
vs History
vs Industry
Median 3Y
-7.2
Median 5Y
-7.5
Industry
3.4
vs History
4
vs Industry
12
Median 3Y
77.4
Median 5Y
61
Industry
8.3
Forward
204.5
vs History
11
vs Industry
5
Median 3Y
191.8
Median 5Y
134
Industry
10.3
vs History
vs Industry
Median 3Y
-12.5
Median 5Y
-11.9
Industry
6.7
Forward
-76.1
vs History
vs Industry
Median 3Y
-12.1
Median 5Y
-11.6
Industry
7.2
Forward
-36.1
vs History
vs Industry
Median 3Y
-16
Median 5Y
-14.8
Industry
8.2
vs History
vs Industry
Median 3Y
-15.7
Median 5Y
-14
Industry
6.7
vs History
vs Industry
0
Median 3Y
-122
Median 5Y
53.2
Industry
5.7

Multiples Across Competitors

EDT Competitors Multiples
Spectral Medical Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
Spectral Medical Inc
TSX:EDT
370.1m CAD 136.8 -8.9 -57.4 -55.3
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 924 975 -161 240.4 -195 797.2 -193 563
US
Abbvie Inc
NYSE:ABBV
395.4B USD 6.6 168.4 16.3 23.2
US
Amgen Inc
NASDAQ:AMGN
171.5B USD 4.8 24.5 17.8 17.8
US
Gilead Sciences Inc
NASDAQ:GILD
153.5B USD 5.3 18.9 12.7 12.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
112.9B USD 9.6 30.7 22.5 23.5
US
Epizyme Inc
F:EPE
94.1B EUR 2 076.6 -529.9 -577 -561.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
77.6B USD 5.4 17 16.1 18.3
AU
CSL Ltd
ASX:CSL
86.6B AUD 3.7 19.3 13 16.2
NL
argenx SE
XBRU:ARGX
46.7B EUR 15.1 35.6 61.6 63.3
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
53.6B USD 16.7 1 230.6 161.8 196.2
P/E Multiple
Earnings Growth PEG
CA
Spectral Medical Inc
TSX:EDT
Average P/E: 193.1
Negative Multiple: -8.9
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -161 240.4 N/A N/A
US
Abbvie Inc
NYSE:ABBV
168.4
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
24.5
45%
0.5
US
Gilead Sciences Inc
NASDAQ:GILD
18.9
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
30.7
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -529.9 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17
9%
1.9
AU
CSL Ltd
ASX:CSL
19.3
11%
1.8
NL
argenx SE
XBRU:ARGX
35.6
40%
0.9
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 230.6
N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CA
Spectral Medical Inc
TSX:EDT
Average EV/EBITDA: 40.2
Negative Multiple: -57.4
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -195 797.2 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.3
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
17.8
11%
1.6
US
Gilead Sciences Inc
NASDAQ:GILD
12.7
7%
1.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
22.5
16%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -577 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.1
11%
1.5
AU
CSL Ltd
ASX:CSL
13
8%
1.6
NL
argenx SE
XBRU:ARGX
61.6
807%
0.1
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
161.8
N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CA
Spectral Medical Inc
TSX:EDT
Average EV/EBIT: 46.4
Negative Multiple: -55.3
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -193 563 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.2
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
17.8
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12.7
12%
1.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.5
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -561.6 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.3
13%
1.4
AU
CSL Ltd
ASX:CSL
16.2
11%
1.5
NL
argenx SE
XBRU:ARGX
63.3
N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
196.2
N/A N/A